Can the PFA‐100® be modified to detect P2Y12 inhibition?
- 17 May 2006
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (6), 1424-1426
- https://doi.org/10.1111/j.1538-7836.2006.01950.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- REGULATION OF PLATELET FUNCTIONS BY P2 RECEPTORSAnnual Review of Pharmacology and Toxicology, 2006
- Aspirin resistance: position paper of the Working Group on Aspirin ResistanceJournal of Thrombosis and Haemostasis, 2005
- Monitoring of Clopidogrel Action: Comparison of MethodsClinical Chemistry, 2005
- Resistance to clopidogrel: A review of the evidenceJournal of the American College of Cardiology, 2005
- Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseasesJournal of Thrombosis and Haemostasis, 2004
- Aspirin and ClopidogrelArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventionsPublished by Oxford University Press (OUP) ,2004
- Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic StrokeStroke, 2003
- Monitoring Aspirin 1 00 mg and Clopidogrel 75 mg Therapy with the PFA-1 00 Device in Patients with Peripheral Arterial DiseaseVascular and Endovascular Surgery, 2003
- Monitoring of antiplatelet therapy with the PFA-100® in peripheral angioplasty patientsPlatelets, 2002